To determine selectivity, the compounds were tested for activity against the related FAD-dependent amine oxidase enzymes LSD1, MAO-A, and MAO-B. LSD1 activity was assessed using a commercially available assay kit (#700120, Cayman Chemical, Ann Arbor, MI, USA), in which the enzyme activity was determined by the horseradish peroxidase-catalyzed oxidation of 10-acetyl-3,7-dihydroxyphenoxazine to the highly fluorescent resorufin in response to H2O2 production. Monoamine oxidase activity was determined using recombinant human MAO-A and MAO-B (M7316-1VL & M7441-1VL, Sigma-Aldrich, St. Louis, MO, USA) and a commercially available assay kit (#V1401, MAO-Glo, Promega, Madison, WI, USA), which utilizes the MAO-catalyzed oxidation of a luciferin derivative coupled with esterase activity to produce luminescence. Fluorescent and luminescent readout was obtained using a SpectraMax M5 plate reader (Molecular Devices) equipped with SOFTmax PRO 7.0.3 software. All the compounds were tested at a concentration of 20 µM and compared to tranylcypromine (TCP) and the vehicle control. Values were reported as mean % inhibition ± SD of triplicate assay wells normalized to background activity and compared to the vehicle control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.